title: [What is reliable in thrombolytic therapy of acute myocardial infarct?].
authors.affiliation: Medizinische Klinik III, Universität Heidelberg.
authors.forename: C
authors.initials: C
authors.lastname: Bode
authors.forename: R
authors.initials: R
authors.lastname: Weber
authors.forename: E
authors.initials: E
authors.lastname: von Hodenberg
authors.forename: W
authors.initials: W
authors.lastname: Kübler
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D012307:Risk Factors
chemical_list: D005343:Fibrinolytic Agents
vernacular_title: Was ist gesichert in der thrombolytischen Therapie des akuten Myokardinfarkts?